scholarly journals Glycyl tRNA Synthetase (GARS) Gene Variant Causes Distal Hereditary Motor Neuropathy V

2018 ◽  
Vol 2018 ◽  
pp. 1-4 ◽  
Author(s):  
Peter Chung ◽  
Hope Northrup ◽  
Misbah Azmath ◽  
Ricardo A. Mosquera ◽  
Shade Moody ◽  
...  

Distal hereditary motor neuropathies (dHMN) are a rare heterogeneous group of inherited disorders specifically affecting the motor axons, leading to distal limb neurogenic muscular atrophy. The GARS gene has been identified as a causative gene responsible for clinical features of dHMN type V in families from different ethnic origins and backgrounds. We present the first cohort of family members of Nigerian descent with a novel heterozygous p.L272R variant on the GARS gene. We postulate that this variant is the cause of dHMN-V in this family, leading to variable phenotypical expressions that are earlier than reported in previous cases. The exact cause for the observed clinical heterogeneity within the family is unknown. One explanation is that there are modifier genes that affect the phenotype. These cases highlight the possibility of considering pathogenic variants in the GARS gene as a potential cause of early onset axonal polyneuropathy with atypical presentation.

2020 ◽  
Author(s):  
Bo Sun ◽  
Zhengqing He ◽  
Yanran Li ◽  
Hongfen Wang ◽  
Fei Yang ◽  
...  

Abstract BackgroundCMT2D is a rare subtype of axonal CMT, caused by a variant of the glycyl-tRNA synthetase (GARS) gene which is also a disease-causing gene of distal spinal muscular atrophy type V (dSMA-V) or hereditary motor neuropathy 5A (HMN5A). There were only several cases reported in China, all lacking an epidemiological study of CMT2D/ HMN5A.Methods206 patients of Chinese Han descent, clinically diagnosed with inherited peripheral neuropathy (IPN), were recruited in this study from December 20, 2012 to July 31, 2019. All patients underwent a detailed medical history screening, a neurological examination, a laboratory examination, several electrophysiological studies, and genetic testing.ResultsA total of 206 unrelated patients underwent genetic analysis. Four variants of GARS from four different families were found, including c.794C > T (p.S265F), c.374A > G (p.E125G), c.1000A > T (p.I334F), and c.781T > G (p.Y261D), with the first three being considered pathogenic. For the three pathogenic variant carriers, one was diagnosed with CMT2D, while the two others were diagnosed with HMN5A.ConclusionGARS mutation is a rare outcome of inherited peripheral neuropathy and the phenotype tends to be CMT2D or HMN5A.


Neurology ◽  
2006 ◽  
Vol 66 (11) ◽  
pp. 1721-1726 ◽  
Author(s):  
O. Dubourg ◽  
H. Azzedine ◽  
R. B. Yaou ◽  
J. Pouget ◽  
A. Barois ◽  
...  

2021 ◽  
Vol 6 (1) ◽  
Author(s):  
Hai-Lin Dong ◽  
Jia-Qi Li ◽  
Gong-Lu Liu ◽  
Hao Yu ◽  
Zhi-Ying Wu

AbstractSorbitol dehydrogenase gene (SORD) has been identified as a novel causative gene of recessive forms of hereditary neuropathy, including Charcot–Marie–Tooth disease type 2 and distal hereditary motor neuropathy (dHMN). Our findings reveal two novel variants (c.404 A > G and c.908 + 1 G > C) and one known variant (c.757delG) within SORD in four Chinese dHMN families. Ex vivo cDNA polymerase chain reaction confirmed that c.908 + 1 G > C variant was associated with impaired splicing of the SORD transcript. In vitro cell functional studies showed that c.404 A > G variant resulted in aggregate formation of SORD and low protein solubility, confirming the pathogenicity of SORD variants. We have provided more evidence to establish SORD as a causative gene for dHMN.


2012 ◽  
Vol 91 (1) ◽  
pp. 139-145 ◽  
Author(s):  
Christian Beetz ◽  
Thomas R. Pieber ◽  
Nicole Hertel ◽  
Maria Schabhüttl ◽  
Carina Fischer ◽  
...  

Neurology ◽  
2020 ◽  
pp. 10.1212/WNL.0000000000011054
Author(s):  
Herminia Argente-Escrig ◽  
Joshua Burns ◽  
Gabrielle Donlevy ◽  
Marina Frasquet ◽  
Kayla Cornett ◽  
...  

Objective:To describe the clinical, genetic and disability profile of pediatric distal hereditary motor neuropathy (dHMN) and to determine the utility of an outcome measure validated for children with Charcot-Marie-Tooth disease (CMT) in assessing disability in this cohort.Methods:We reviewed the clinical, neurophysiologic, and disability data on individuals with dHMN, evaluated before the age of 20 years, at two tertiary neuromuscular clinics in Australia and Spain. Disability was assessed annually with the CMT Pediatric Scale (CMTPedS) in a subset of individuals.Results:Twenty-two children (13 females) from 19 families were included. 14 individuals were symptomatic in the first year of life. Intellectual disability was present in six individuals and upper motor neuron signs, in eight. Pathogenic variants were found in nine families, more frequently in BICD2 (BICD2-4, DYNC1H1-2, MFN2-2, GARS-1). A novel pathogenic variant in the GARS gene was detected and characterized phenotypically. Disability was moderate on the CMTPedS (mean [SD], 18.2 [6.3], n=16), with balance and long jump being the most affected and sensation items and grip strength, the least. Over one year the CMTPedS total score deteriorated, on average 1.5 points (SD 3.7) or 9% (n=12), with significant variability in the rate of progression within the cohort.Conclusions:The genetic profile of pediatric dHMN is different to that identified in adult cohorts. This study has identified distinct functional limitations on the CMTPedS in children and adolescents with dHMN.


2012 ◽  
Vol 17 (4) ◽  
pp. 418-421 ◽  
Author(s):  
Hye Jin Lee ◽  
Jin Park ◽  
Khriezanou Nakhro ◽  
Jin Mo Park ◽  
Yoon-Mi Hur ◽  
...  

2012 ◽  
Vol 112 (1) ◽  
pp. 57-64 ◽  
Author(s):  
Manuela Pennisi ◽  
Alberto Raggi ◽  
Rita Barone ◽  
Maria Muglia ◽  
Luigi Citrigno ◽  
...  

Neurology ◽  
2012 ◽  
Vol 78 (21) ◽  
pp. 1644-1649 ◽  
Author(s):  
Z. Zhao ◽  
A. Hashiguchi ◽  
J. Hu ◽  
Y. Sakiyama ◽  
Y. Okamoto ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document